This is an ISUOG approved course organised by IOTA.
Join leading international experts for this practical, evidence-based pre-congress course focused on the role of ultrasound in the diagnosis and management of women with suspected gynaecological cancer.
Designed for clinicians working in ultrasound, gynaecology and gynaecological oncology, the programme will provide the latest updates on the assessment of ovarian, endometrial and myometrial pathology, with a particular focus on the application of the IOTA and IETA approaches in clinical practice.
Through expert lectures and interactive case discussions, participants will learn how to classify ovarian masses using the latest IOTA terminology and the ADNEX model, manage complex scenarios such as masses in pregnancy and younger women, investigate postmenopausal bleeding, and recognise key features of endometrial and myometrial pathology. The course will also explore emerging developments in artificial intelligence and its potential impact on ultrasound diagnostics and rapid access cancer pathways.
The programme concludes with practical guidance on implementing risk prediction models, assessing tumour spread, and managing common clinical challenges encountered in rapid access clinics.
Key learning objectives:
- Apply the latest IOTA terminology, benign descriptors and ADNEX model to classify ovarian pathology.
- Recognise ultrasound features of common and less common ovarian, endometrial and myometrial conditions.
- Improve assessment and management of women presenting with postmenopausal bleeding.
- Understand the role of saline and gel infusion techniques and endometrial biopsy in diagnosing focal pathology.
- Explore the current and future role of artificial intelligence in gynaecological ultrasound.
- Gain practical insights into establishing and running an effective rapid access gynaecological cancer diagnostic service.
This course offers a unique opportunity to learn from internationally recognised experts and enhance your confidence in the ultrasound-based assessment of women with suspected gynaecological malignancy.
To find out more and to register, click here.